Pfizer to Make Billions from Treating ‘Heart Failure Pandemic’

Pharmaceutical giant Pfizer has just invested billions of dollars into treatments for a looming “heart failure pandemic.”

Pfizer, the same company that sold you the so-called vaccines, is making a big bet on that “heart failure pandemic.”

The pharmaceutical giant recently acquired several companies.

This includes a major $6.7 billion cash acquisition of Arena Pharmaceuticals, a firm specializing in developing treatments, particularly for heart inflammation conditions like myocarditis and pericarditis.

The company is expected to make tens of billions of dollars in profits from the spike in heart failure.

So, the company that caused the heart damage is now looking to profit from heart damage.

The news comes as scientists are now warning that the latest COVID variant could trigger a “heart failure pandemic.”

Research into the new strain known as JN.1, could cause a “global healthcare risk” related to COVID-19, stating that it could start a “heart failure pandemic.”

Health experts have warned that there is an increase in the chances of potential heart issues for those who catch the disease.

Due to the influx of a new strain JN.1, there has been a spike in Covid cases in several countries.

Scientists are claiming that new strains are responsible for the

SHARE THIS:

READ MORE >>>

Subscribe to Our Free Newsletter

VIEW MORE NEWS